Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Canagliflozin

Canagliflozin

Inquiry
  Post Date: Oct 13,2013
  Expiry Date: Oct 13,2014
  Detailed Description: Cas No. :842133-18-0 Canagliflozin is a drug for the treatment of type 2 diabetes . Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine
In March 2013, Canagliflozin became the first SGLT2 inhibitor to be approved in the United States.

  CAS Registry Number:

842133-18-0
  Synonyms: ;(1s)-1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-d-glucitol;1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;Canaglifozin;
  Molecular Formula: C24H25FO5S
  Molecular Weight: 444.52
  Molecular Structure: 842133-18-0 canagliflozin

  Company: Stereokem     [ United States ]        
  Contact: Sundar Venkataraman
  Tel: +1-415-290-0331
  Fax:
  Email: Sundar@stereokem.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.